Financial and feasibility implications of the treatment of hepatitis C virus in Italy: scenarios and perspectives

Davide Croce1 Center for Research on Health Economics, Social and Health Care Management, Università Cattaneo, Castellanza, Italy;2 School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaCorrespondence[email protected]

Marzia Bonfanti1 Center for Research on Health Economics, Social and Health Care Management, Università Cattaneo, Castellanza, Italy

Umberto Restelli1 Center for Research on Health Economics, Social and Health Care Management, Università Cattaneo, Castellanza, Italy;2 School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (6)

Macarena Garrido-Estepa, Pello Latasa, Javier Flores-Herrera & Luis García Comas. (2020) Hepatitis C and hepatitis C-related advanced liver disease hospitalisation trends before and after the Strategic Plan for Tackling Hepatitis C in the National Health System. European Journal of Gastroenterology & Hepatology 33:10, pages 1307-1315.
Crossref

Juan José Vegas, Javier Flores‐Herrera, Pello Latasa & Macarena Garrido‐Estepa. (2021) Reduction in hepatitis C‐related hospitalizations after the implementation of the Strategic Plan for Tackling Hepatitis C in the Spanish National Health System: regional level differences. Journal of Viral Hepatitis 28:6, pages 859-869.
Crossref

Massimo Andreoni, Giovanni Di Perri, Marcello Persico, Andrea Marcellusi, Olivier Ethgen, Yuri Sanchez Gonzalez, Mark Bondin, Zhenzhen Zhang, Antonella De Michina, Rocco Cosimo Damiano Merolla & Antonio Craxì. (2021) Addressing HCV Elimination Barriers in Italy: Healthcare Resource Utilization and Cost Impact Using 8 Weeks’ Glecaprevir/Pibrentasvir Therapy. Infectious Diseases and Therapy 10:2, pages 763-774.
Crossref

Loreta A. Kondili, Massimo Andreoni, Alfredo Alberti, Salvatore Lobello, Sergio Babudieri, Antonio Saverio Roscini, Rocco Merolla, Walter Marrocco & Antonio Craxì. (2021) Estimated prevalence of undiagnosed HCV infected individuals in Italy: A mathematical model by route of transmission and fibrosis progression. Epidemics 34, pages 100442.
Crossref

Masoud Behzadifar, Hasan Abolghasem Gorji, Aziz Rezapour & Nicola Luigi Bragazzi. (2019) The hepatitis C infection in Iran: a policy analysis of agenda-setting using Kingdon’s multiple streams framework. Health Research Policy and Systems 17:1.
Crossref

R. Ragusa, G. Bertino, A. Bruno, E. Frazzetto, F. Cicciu, G. Giorgianni & L. Lupo. (2018) Evaluation of health status in patients with hepatitis c treated with and without interferon. Health and Quality of Life Outcomes 16:1.
Crossref

Financial and feasibility implications of the treatment of hepatitis C virus in Italy: scenarios and perspectives

Articles from other publishers (6)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Financial and feasibility implications of the treatment of hepatitis C virus in Italy: scenarios and perspectives

Citations (6)

Articles from other publishers (6)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date